| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/29/2010 | CA2274498C Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 06/29/2010 | CA2218364C Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
| 06/29/2010 | CA2134030C Soluble interferon .alpha.-receptor, its preparation and use |
| 06/24/2010 | WO2010071853A1 Thiazolopyridine sirtuin modulating compounds |
| 06/24/2010 | WO2010070615A1 Cysteine protease inhibitors |
| 06/24/2010 | WO2010070141A2 Compositions comprising adipose stem cells |
| 06/24/2010 | WO2010069949A1 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis |
| 06/24/2010 | WO2010069595A1 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
| 06/24/2010 | WO2010069204A1 Pluripotent stem cells, method for preparation thereof and uses thereof |
| 06/24/2010 | WO2010037856A3 DYNACTIN-1/p150glued AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY AND A METHOD FOR IDENTIFYING TARGETABLE DISEASE-RELATED PROTEINS |
| 06/24/2010 | WO2010028015A3 2-oxo-1,2-dihydro-quinoline modulators of immune function |
| 06/24/2010 | WO2010025324A3 Nanoparticles for immunotherapy |
| 06/24/2010 | WO2010023482A3 Therapeutic antibody |
| 06/24/2010 | WO2010010112A3 Construct and method for the internalization of cargo molecules into a cell |
| 06/24/2010 | WO2010005958A3 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 06/24/2010 | WO2009135615A3 Means for the treatment and/or prophylaxis of an autoimmune disease and for the formation of regulatory t-cells |
| 06/24/2010 | WO2009098454A3 Treatment of diseases and conditions mediated by eicosanoids |
| 06/24/2010 | US20100160420 Novel simian t-cell lymphotropic virus |
| 06/24/2010 | US20100160419 Compositions and Methods for Vaccinating Against HSV-2 |
| 06/24/2010 | US20100160415 Compositions and methods for treatment of autoimmune disease |
| 06/24/2010 | US20100160409 Highly Branched Reagents For Modifying Biopharmaceuticals, Their Preparation And Use |
| 06/24/2010 | US20100160392 Histone deacetylase inhibitors |
| 06/24/2010 | US20100160389 Dihydropyridone amidesas p2x7 modulators |
| 06/24/2010 | US20100160388 Dihydropyridone ureas as p2x7 modulators |
| 06/24/2010 | US20100160387 Dihydropyridone amides as p2x7 modulators |
| 06/24/2010 | US20100160371 Inhibition of p38 kinase activity by aryl ureas |
| 06/24/2010 | US20100160369 S1P1 Agonists and Methods of Making And Using |
| 06/24/2010 | US20100160366 Treatment method |
| 06/24/2010 | US20100160357 Heterobicyclic sphingosine 1-phosphate analogs |
| 06/24/2010 | US20100160349 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 06/24/2010 | US20100160347 PYRIDO[1,2-a]PYRIMIDIN-4-ONE INHIBITORS OF MAST CELL DEGRANULATION |
| 06/24/2010 | US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 06/24/2010 | US20100160329 Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases |
| 06/24/2010 | US20100160320 C5aR ANTAGONISTS |
| 06/24/2010 | US20100160318 3-Pyrrolo[b]Cyclohexylene-2-Dihydroindolinone Derivatives and Uses Thereof |
| 06/24/2010 | US20100160314 Small Molecule Inhibitors of Toll-Like Receptor 9 |
| 06/24/2010 | US20100160292 Kinase Inhibitors, and Methods of Using and Identifying Kinase Inhibitors |
| 06/24/2010 | US20100160287 Compounds useful as inhibitors of janus kinases |
| 06/24/2010 | US20100160271 Bicyclic modulators of h1 receptors |
| 06/24/2010 | US20100160253 Sulphated xylans for treatment or prophylaxis of respiratory diseases |
| 06/24/2010 | US20100160238 TGFP-CAP Peptide and its Uses |
| 06/24/2010 | US20100160221 Effect of tula on hiv |
| 06/24/2010 | US20100160219 Novel Polypeptides Inducing Dendritic Cell Migration, as Well as Medicines and Pharmaceutical Compositions Containing Same |
| 06/24/2010 | US20100159453 Genes involved in intestinal inflammatory diseases and use thereof |
| 06/24/2010 | US20100158981 Block Biodegradable Copolymers for Medical Devices |
| 06/24/2010 | US20100158955 Phl p 5a derivatives having reduced allergeneity and retained t-cell reactivity |
| 06/24/2010 | US20100158953 Method for controlling streptococcus pneumoniae serotype 19a polysaccharide molecular weight |
| 06/24/2010 | US20100158952 Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates |
| 06/24/2010 | US20100158946 Secretory IgA and IgG Antibody Inducer |
| 06/24/2010 | US20100158942 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 06/24/2010 | US20100158941 Compositions and Methods for Treating Microbial Infections |
| 06/24/2010 | US20100158934 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
| 06/24/2010 | US20100158933 Ige ch3 peptide vaccine |
| 06/24/2010 | US20100158932 Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof |
| 06/24/2010 | US20100158930 Hpv antigen fusion protein vaccine compositions and uses thereof |
| 06/24/2010 | US20100158922 Anti-Interferon Gamma Antibodies and Methods of Use Thereof |
| 06/24/2010 | US20100158918 Polypeptides and polynucleotides encoding same |
| 06/24/2010 | US20100158913 Antibody Molecules Having Specificity for Human IL-1B |
| 06/24/2010 | US20100158909 Variant Target Binding Agents and Uses Thereof |
| 06/24/2010 | US20100158908 Stable Polypeptide Formulations |
| 06/24/2010 | US20100158906 Use of recombinant monoclonal antibody with specific binding activity for cell surface phosphorylated glycoprotein in diagnosis and treatment of immune, cell proliferative and inflammatory disorders |
| 06/24/2010 | US20100158902 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 06/24/2010 | US20100158901 Anti-cd19 antibody therapy for autoimmune disease |
| 06/24/2010 | US20100158899 Protein formulation |
| 06/24/2010 | US20100158882 Immunomodulating probiotic lactic acid bacteria |
| 06/24/2010 | US20100158878 Target populations of oligodendrocyte precursor cells and methods of making and using same |
| 06/24/2010 | US20100158861 Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus |
| 06/24/2010 | US20100158843 Novel 3-phenylpropanoic compound activators of receptors of ppar type and pharmaceutical/cosmetic compositions comprised thereof |
| 06/24/2010 | US20100158817 T1 mri trackable drug delivery particles, uses and methods thereof |
| 06/24/2010 | DE102008063046A1 Medizinische Verwendung des ribosomalen Protein S19 (RPS19) Medical use of the ribosomal protein S19 (RPS19) |
| 06/24/2010 | CA2747715A1 Thiazolopyridine sirtuin modulating compounds |
| 06/24/2010 | CA2744888A1 Cysteine protease inhibitors |
| 06/24/2010 | CA2743397A1 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis |
| 06/24/2010 | CA2737335A1 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
| 06/23/2010 | EP2199793A1 Method of evaluating human dendritic cells and human cell immunotherapeutic agent |
| 06/23/2010 | EP2199307A1 Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex |
| 06/23/2010 | EP2199284A1 Pharmaceutical composition for inhibiting accumulation of amyloid- beta protein |
| 06/23/2010 | EP2198882A2 Nucleic acid mucosal immunization |
| 06/23/2010 | EP2198879A1 CD74 modulator agent for regulating dendritic cell migration and device for studying the motility capacity of a cell |
| 06/23/2010 | EP2198877A2 Orally administered peptides to ameliorate atherosclerosis |
| 06/23/2010 | EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors |
| 06/23/2010 | EP2198858A1 Sustained release preparation of a macrolide compound like tacrolimus |
| 06/23/2010 | EP2198723A1 Inflammation inhibiting compounds |
| 06/23/2010 | EP2197832A1 Novel aryl potassium channel blockers and uses thereof |
| 06/23/2010 | EP2197494A2 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion |
| 06/23/2010 | EP2197477A2 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s) |
| 06/23/2010 | EP2197470A2 Use of bubuc and optionally eaa-mart1 (26-35) as a therapeutic agent for the treatment of hcmv infections |
| 06/23/2010 | EP2197466A2 Use of retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections |
| 06/23/2010 | EP2197462A2 Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agent |
| 06/23/2010 | EP2197442A1 Polo-like kinase inhibitors |
| 06/23/2010 | EP1511734B1 Compounds, compositions, and methods |
| 06/23/2010 | EP1416959B1 Liposomes prepared from the extractable lipids from a mycobacterium |
| 06/23/2010 | CN1871351B Novel fungal proteins and nucleic acids encoding same |
| 06/23/2010 | CN1820026B Human anti-IFN-gamma neutralizing antibodies as selective IFN-gamma pathway inhibitors |
| 06/23/2010 | CN1589166B Stent coated with a sustained-release drug delivery system and method for use thereof |
| 06/23/2010 | CN101754980A Prevention and treatment of complement-associated eye conditions |
| 06/23/2010 | CN101754767A Treatment of graft-versus-host disease |
| 06/23/2010 | CN101748179A Preparation method of feather protein peptide |
| 06/23/2010 | CN101748096A Sub totipotential stem cell and preparation method and application thereof |